UNIVERSITY PARK, Pa. — Matthew Aronson, a senior majoring in biomedical engineering at Penn State, spent the summer of 2019 in Germany as a scholar in the German Academic Exchange Service (DAAD) Research Internships in Science and Engineering (RISE) program.
Aronson, from Newtown, Pennsylvania, was one of approximately 300 undergraduates from North America, Great Britain and Ireland selected from nearly 2,000 applications to conduct research at top German universities and institutions. The internships give each student an opportunity to perform research at one of Germany's top universities or research institutions. Aronson’s internship took place at the Technical University of Kaiserslautern in Kaiserslautern, Germany.
Aronson investigates the presence of antimicrobial compounds secreted by terrestrial blue-green algae, known as cyanobacteria. He works to extract, purify and characterize the compounds for use in cancer and antibiotic research.
“I worked in the bioprocess engineering department at the university, where they focused on understanding different culture conditions of different kinds of bacteria and plants,” Aronson said. “One part of the lab works to optimize growing the bacteria and plants and another part extracts different bioactive compounds from the plants or bacteria. Once this is done, the researchers then study how to use those compounds to kill bacteria, fungus, other plants or cancer cells. They then develop new pharmaceuticals based on those compounds.”
In Germany, Aronson and his fellow researchers grew the terrestrial cyanobacteria in 10-liter tanks. Once grown, he extracted the compounds from the algae and used several different techniques that he learned to characterize them.
The bridge connecting research at Penn State and Germany
“One of the reasons why the internship was a very good experience was because of how much of the work I did at the University of Kaiserslautern relates to the research I do here at Penn State,” Aronson said.
Aronson is an undergraduate researcher in the lab of Scott Medina, assistant professor of biomedical engineering. His research involves working with peptides, short chains of amino acids, extracted from compounds similar to what he worked with in Germany.
“These peptides are naturally produced by tons of organisms like bacteria, and I find the sequences of how the amino acids are joined in the peptides in the existing literature,” Aronson said. “This enables me to make synthetic peptides that can hopefully be used to kill cancer cells and harmful bacteria.”
The ultimate goal of Aronson’s research is to develop new cancer drugs with fewer side effects. During his internship, Aronson was exposed to every sector of pharmaceutical research using peptides, complementing the engineering-heavy work he does at Penn State.